Cytoskeleton dynamics during neurotransmitter release. 1993

J M Trifaró, and M L Vitale
Dept of Pharmacology, University of Ottawa, Canada.

It has become apparent in recent years that the cytoskeleton and its associated proteins play a major role in secretion. This review summarizes recent findings on the cytoskeleton organization and the molecular topology of its regulatory proteins, as well as the dynamic changes that occur in this organelle during secretion from neurons and secretory cells. Although two apparently different ultrastructures and molecular organizations of the cytoskeleton seem to be involved in neuronal and secretory cell secretion, there are similarities between the two systems. In both neurons and secretory cells, Ca2+ plays a pivotal role in the control of cytoskeleton dynamics, especially in the changes in actin filament networks observed during secretion.

UI MeSH Term Description Entries
D009411 Nerve Endings Branch-like terminations of NERVE FIBERS, sensory or motor NEURONS. Endings of sensory neurons are the beginnings of afferent pathway to the CENTRAL NERVOUS SYSTEM. Endings of motor neurons are the terminals of axons at the muscle cells. Nerve endings which release neurotransmitters are called PRESYNAPTIC TERMINALS. Ending, Nerve,Endings, Nerve,Nerve Ending
D003599 Cytoskeleton The network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm. Cytoplasmic Filaments,Cytoskeletal Filaments,Microtrabecular Lattice,Cytoplasmic Filament,Cytoskeletal Filament,Cytoskeletons,Filament, Cytoplasmic,Filament, Cytoskeletal,Filaments, Cytoplasmic,Filaments, Cytoskeletal,Lattice, Microtrabecular,Lattices, Microtrabecular,Microtrabecular Lattices
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

J M Trifaró, and M L Vitale
April 2000, Biochimie,
J M Trifaró, and M L Vitale
January 1996, International review of neurobiology,
J M Trifaró, and M L Vitale
August 1990, FEBS letters,
J M Trifaró, and M L Vitale
January 1996, Annual review of neuroscience,
J M Trifaró, and M L Vitale
January 2008, Handbook of experimental pharmacology,
J M Trifaró, and M L Vitale
May 1992, The New biologist,
J M Trifaró, and M L Vitale
December 1987, Science (New York, N.Y.),
J M Trifaró, and M L Vitale
March 2011, Molecular biology of the cell,
Copied contents to your clipboard!